Financials
- Market Capitalization 2.67 M
- Employee 11
- Founded 2007
- CEO N/A
- Website www.organovo.com
- Headquarter Delaware, United States
- FIGI BBG001M8GFD0
- Industry 医薬品メーカー(一般)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.27
売上高対価格比率
28.25
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4848 | QCLS Q/C Technologies, Inc. - Common Stock | 0.56 USD | -3.45% | -21.13% | -65.00% | -85.42% | 4.59 M USD | ||
| 4913 | KAPA Kairos Pharma, Ltd. Common Stock | 0.80 USD | -3.61% | -33.33% | -53.22% | +37.93% | 2.71 M USD | ||
| 4921 | PPCB Propanc Biopharma, Inc. - Common Stock | 0.42 USD | -4.55% | -17.65% | -53.33% | -76.71% | 2.66 M USD | ||
| 5016 | DCOY Decoy Therapeutics Inc. - Common Stock | 1.30 USD | -9.09% | -17.72% | -56.08% | +60.73% | 851.74 K USD |